CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?

Battastini, A. M. O., Figueiró, F., Leal, D. B. R., Doleski, P. H., & Schetinger, M. R. C. (2021, March 11). CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations? Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.633603